Guggenheim Capital’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Sell
25,888
-418
-2% -$25.6K 0.01% 900
2026
Q1
$1.72M Buy
26,306
+8,296
+46% +$607K 0.01% 756
2025
Q4
$1.45M Sell
18,010
-4,069
-18% -$327K 0.01% 773
2025
Q3
$1.81M Buy
22,079
+13,477
+157% +$1.17M 0.01% 708
2025
Q2
$785K Sell
8,602
-141
-2% -$12.6K 0.01% 975
2025
Q1
$800K Sell
8,743
-179
-2% -$15.6K 0.01% 971
2024
Q4
$760K Sell
8,922
-8,038
-47% -$705K 0.01% 1037
2024
Q3
$1.48M Sell
16,960
-13,088
-44% -$1.1M 0.01% 941
2024
Q2
$2.37M Sell
30,048
-15,966
-35% -$1.31M 0.02% 753
2024
Q1
$4.16M Sell
46,014
-1,389
-3% -$127K 0.03% 620
2023
Q4
$4.17M Buy
47,403
+20,443
+76% +$1.7M 0.03% 580
2023
Q3
$2.28M Buy
26,960
+3,911
+17% +$353K 0.02% 764
2023
Q2
$2.28M Sell
23,049
-452
-2% -$42.5K 0.02% 802
2023
Q1
$2.26M Sell
23,501
-21,650
-48% -$2M 0.02% 800
2022
Q4
$4.1M Sell
45,151
-1,895
-4% -$161K 0.04% 595
2022
Q3
$3.74M Sell
47,046
-1,436
-3% -$122K 0.03% 606
2022
Q2
$4.04M Buy
48,482
+117
+0.2% +$9.64K 0.03% 631
2022
Q1
$3.98M Sell
48,365
-95
-0.2% -$7.44K 0.02% 745
2021
Q4
$3.63M Sell
48,460
-264
-0.5% -$19.8K 0.02% 811
2021
Q3
$3.69M Buy
48,724
+2,522
+5% +$195K 0.02% 788
2021
Q2
$3.57M Buy
46,202
+7,264
+19% +$561K 0.02% 804
2021
Q1
$2.73M Buy
38,938
+15,661
+67% +$1.18M 0.02% 875
2020
Q4
$1.65M Hold
23,277
0.01% 1062
2020
Q3
$1.34M Sell
23,277
-1,167
-5% -$69.8K 0.01% 1081
2020
Q2
$1.49M Sell
24,444
-313
-1% -$19.3K 0.01% 1015
2020
Q1
$1.36M Sell
24,757
-1,045
-4% -$70.1K 0.01% 957
2019
Q4
$1.86M Sell
25,802
-6,427
-20% -$438K 0.01% 1066
2019
Q3
$2.13M Buy
32,229
+18,796
+140% +$1.21M 0.02% 983
2019
Q2
$834K Sell
13,433
-5,505
-29% -$318K 0.01% 1430
2019
Q1
$1.02M Sell
18,938
-96,940
-84% -$5.45M 0.01% 1367
2018
Q4
$6.79M Sell
115,878
-20,869
-15% -$1.31M 0.06% 411
2018
Q3
$9.02M Buy
136,747
+85,923
+169% +$5.68M 0.06% 393
2018
Q2
$3.36M Sell
50,824
-497
-1% -$33.4K 0.02% 943
2018
Q1
$3.42M Buy
51,321
+40,887
+392% +$2.75M 0.01% 1251
2017
Q4
$682K Sell
10,434
-30,597
-75% -$1.99M ﹤0.01% 2251
2017
Q3
$2.64M Sell
41,031
-1,900
-4% -$123K 0.01% 1473
2017
Q2
$2.77M Buy
42,931
+5,745
+15% +$363K 0.01% 1391
2017
Q1
$2.27M Sell
37,186
-16,745
-31% -$1.01M 0.01% 1567
2016
Q4
$3.14M Buy
53,931
+1,089
+2% +$64.2K 0.01% 1312
2016
Q3
$3.06M Sell
52,842
-6,065
-10% -$357K 0.01% 1318
2016
Q2
$3.4M Buy
58,907
+2,269
+4% +$130K 0.01% 1222
2016
Q1
$3.42M Sell
56,638
-13,063
-19% -$732K 0.01% 1215
2015
Q4
$3.8M Buy
69,701
+19,872
+40% +$1.14M 0.01% 1167
2015
Q3
$2.83M Sell
49,829
-4,835
-9% -$277K 0.01% 1356
2015
Q2
$2.98M Sell
54,664
-688
-1% -$37.8K 0.01% 1460
2015
Q1
$3.01M Buy
55,352
+7,246
+15% +$366K 0.01% 1458
2014
Q4
$2.24M Buy
48,106
+6,657
+16% +$312K 0.01% 1650
2014
Q3
$1.9M Sell
41,449
-2,578
-6% -$121K ﹤0.01% 1795
2014
Q2
$2.04M Buy
44,027
+552
+1% +$26K 0.01% 1804
2014
Q1
$2.02M Sell
43,475
-660
-1% -$28.9K 0.01% 1793
2013
Q4
$1.82M Buy
44,135
+7,159
+19% +$282K 0.01% 1870
2013
Q3
$1.35M Buy
36,976
+10,315
+39% +$390K ﹤0.01% 1898
2013
Q2
$989K Buy
+26,661
New +$952K ﹤0.01% 2045

Other funds holding DOX

Guggenheim Capital's DOX Position: Q2 2026 in Review

Guggenheim Capital reduced its Amdocs (DOX) stake by 1.6% in Q2 2026, selling an estimated $25.6K and leaving 25,888 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #900.

Guggenheim Capital first reported a position in DOX in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.02M in Q3 2018. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Guggenheim Capital held 25,888 shares of Amdocs worth $1.31M as of Q2 2026.
  • Guggenheim Capital sold 418 Amdocs shares in Q2 2026, an estimated $25.6K.
  • Amdocs made up 0.01% of Guggenheim Capital's portfolio in Q2 2026, its #900 holding.
  • Guggenheim Capital first reported a position in Amdocs in Q2 2013 and has held it in 53 quarters since.
  • Guggenheim Capital's Amdocs position peaked at $9.02M in Q3 2018.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.